CASI Pharmaceuticals
CASI
CASI
51 hedge funds and large institutions have $36.4M invested in CASI Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $37.3M → $36.4M (-$895K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$581K | |
| 2 | +$414K | |
| 3 | +$178K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$104K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$93.6K |
Top Sellers
| 1 | -$3.6M | |
| 2 | -$133K | |
| 3 | -$122K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$80.3K |
| 5 |
HF
HRT Financial
New York
|
-$53K |